Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Theravance Biopharma (TBPH) Change in Acquisitions & Divestments: 2013-2025

Historic Change in Acquisitions & Divestments for Theravance Biopharma (TBPH) over the last 11 years, with Sep 2025 value amounting to $24.5 million.

  • Theravance Biopharma's Change in Acquisitions & Divestments fell 10.90% to $24.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $117.5 million, marking a year-over-year increase of 8.37%. This contributed to the annual value of $139.8 million for FY2024, which is 95.88% up from last year.
  • Latest data reveals that Theravance Biopharma reported Change in Acquisitions & Divestments of $24.5 million as of Q3 2025, which was up 20.39% from $20.4 million recorded in Q2 2025.
  • Theravance Biopharma's 5-year Change in Acquisitions & Divestments high stood at $115.5 million for Q1 2021, and its period low was $8.7 million during Q2 2023.
  • Its 3-year average for Change in Acquisitions & Divestments is $32.1 million, with a median of $28.2 million in 2024.
  • In the last 5 years, Theravance Biopharma's Change in Acquisitions & Divestments plummeted by 79.95% in 2023 and then soared by 226.06% in 2024.
  • Over the past 5 years, Theravance Biopharma's Change in Acquisitions & Divestments (Quarterly) stood at $64.8 million in 2021, then declined by 23.92% to $49.3 million in 2022, then crashed by 79.95% to $8.7 million in 2023, then skyrocketed by 226.06% to $40.1 million in 2024, then declined by 10.90% to $24.5 million in 2025.
  • Its Change in Acquisitions & Divestments was $24.5 million in Q3 2025, compared to $20.4 million in Q2 2025 and $32.6 million in Q1 2025.